DrugDev competitors

Marc’s career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel and GlaxoSmithKline (GSK), has given him extensive industry experience, including finance and accounting; corporate strategy and planning; research and development; sales and marketing; business reorganisation; and business development. Marc is a qualified accountant and joined AstraZeneca in 2013, serving as Executive Vice-President, GPPS from June to October 2013. Prior to that, he served as Global Head of Rare Diseases at GSK and (concurrently) Chairman, GSK Japan. He holds an MBA from HEC, Paris and a Bachelor of Law degree from Paris University.

Chief Executive Officer | Board Director | Healthcare Technology | Software and Service Leader for HCIT and Life Sciences | McKinsey & Company | Veteran

Gary Hughes is co-founder and CEO of Teckro. He is an entrepreneur who has successfully launched two global companies in Ireland - more than a decade ahead of the start-up boom and withstanding the dot-com bust. Combining a passion for design with love of technology, Gary is influenced by Dieter Rams’ principles of good design. He co-founded Teckro with a motivation to make an impact and the belief that clinical research needs to be simpler and more accessible. Gary started his career in the budding e-learning market in the mid 1990s, first working at Dublin-based Interactive Services as a graphic designer. Gary later relocated to the US to gain international experience. Here he worked as a program manager for Microsoft on their Step-by-Step Interactive Training programs before moving back to Ireland to join an early stage start-up based in Galway as one of its first employees. It was a formative experience that led Gary to start Firecrest Clinical in 2001 along with Nigel Hughes and Jacek Skrzypiec. At its inception, Firecrest was an e-learning solution that provided online training for healthcare professionals. By 2004, Firecrest evolved into an investigator portal - one of the first site-facing solutions in the market. In 2011, after a decade, Gary and the Firecrest management team accepted an acquisition offer from ICON, one of the world’s largest clinical research organizations. Post-acquisition, Gary remained with ICON for a couple of years as Executive Vice President. In this time, he gained a greater appreciation for the scale of the problems facing modern drug development processes. Inspired for a second time, Gary, along with co-founders Nigel and Jacek, started Teckro in 2015. Today, Teckro has more than 100 employees across Europe and the United States, with ambitious future growth plans.

Gadi Lachman previously held leadership positions at TriZetto, American Well and Eliza. He was also at Lehman Brothers and was an Officer in Israeli Special Forces. Gadi earned his MBA at Harvard Business School, and his LLB in law and B.C. in accounting from Tel-Aviv University.